Category Archives: U.S. Policy and Funding

An update on the anti-prostitution pledge

By on .

This question and answer session with Rebekah Diller, the deputy director of the Justice Program at the Brennan Center for Justice at the New York University School of Law, discusses the anti-prostitution pledge faced by grantees of the U.S. President’s emergency Plan for AIDS Relief (PEPFAR). What is the anti-prostitution pledge (also known as the […]

AP news article cites fraud in four Global Fund grants

By on .

A news report published Sunday by the Associated Press, claiming broad misuse of funds granted by The Global Fund to Fight AIDS, Tuberculosis and Malaria, is causing quite a stir in the global health community and spurred a response from the Fund Monday.

The headline for the AP story – “Fraud plagues global health fund” – would appear to be misleading since the article and the Fund are discussing fraud affecting only a very small number of grants. The Fund is seeking recovery of $34 million in misused funds, which is 0.26 percent of Global Fund disbursements to date…

112th Congress & Global Health: Additional Profiles of Key Republican House Leaders

By on .

This article is a follow-up to an earlier post to Science Speaks exploring Republican members of the new Congress who are key players in global health policy and funding.

Rep. Denny Rehberg (R-MT), Rep. Ileana Ros-Lehtinen (R-FL), Rep. Christopher Smith (R-NJ), Rep. Dana Rohrabacher (R-CA), and Rep. Joe Pitts (R-PA) are examined, including their voting records on key legislation such as whether or not they supported the President’s Emergency Plan for AIDS Relief, or PEPFAR.

Profiles of House Republicans key to global health funding

By on .

A tough political environment for global health funding

The new Congress brings about a number of important changes to the U.S. House of Representatives’ Appropriations Subcommittee, which determines most of the funding levels for U.S. global health programs through the State and Foreign Operations Subcommittee. Among other programs, this subcommittee plays a major role in determining annual funding levels for the President’s Emergency Plan for AIDS Relief (PEPFAR) program, global tuberculosis, and the Global Fund to Fight AIDS, TB and Malaria. It can also use the appropriations process to effect policy changes by conditioning the use of funds.

Can the U.S. re-emerge as a force in medical innovation?

By on .

That was the question addressed in a symposium held at the Newseum in Washington, DC, Wednesday. “The goal is not only economic strength and the creation of jobs,” said former House Majority Leader Dick Gephardt, one of many high-level panelists invited to participate at the symposium. “But I firmly believe we will reduce health care […]

In brief: Emanuel departs from White House post

By on .

Zeke Emanuel, MD, PhD, has returned to his station directing the Bioethics Department at the National Institutes of Health.  Dr. Emanuel joined the White House Office of Management & Budget (OMB) as a special advisor on health policy to Peter Orzag, director of the OMB, in February 2009. According to reports from Kaiser Health News and […]